DOCS vs VTRS · P/E 21, rev $570.4M vs rev $14.74B
Doximity Inc (DOCS) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported VTRS revenue for 2024-12-31 was $14.74B. Net income was -$634.2M. Revenue was down 4.5% from 2023-12-31 to 2024-12-31. VTRS currently screens at market cap $10.83B.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the DOCS and VTRS stock pages for the full models.
Not investment advice.